Northern NSW Women Urged To Book Breast Screening
Health authorities are urging eligible women to make time for a free mammogram, with 45.2 per cent across…
Comedian Judith Lucy injured ‘coping’ with ‘rollercoaster’ cancer journey
Comedian Judith Lucy has fallen and injured her head as a result of “coping” with her recent cancer…
Finnish study finds poor oral health increases jawbone necrosis risks in breast cancer patients
Antiresorptive drugs, which reduce bone breakdown, are an important part of treatment for breast cancer that has spread…
Judith Lucy’s cancer journey will reveal resilience she didn’t know she had
Welcome, Judith Lucy, to the After Cancer Diagnosis Club. It’s a club no-one wants to join. There are…
Automated ultrasound offers reliable alternative for screening women with dense breasts
A new study in the Journal of the American College of Radiology, published by Elsevier, has found that…
How caring for her dying father at 17 shaped this KKH nurse’s care for breast cancer patients
Ng has seen how powerful love can be in the face of a life-threatening diagnosis. She recalls a…
Judith Lucy reveals breast cancer diagnosis, mastectomy ahead
Beloved comedian Judith Lucy has revealed she has been diagnosed with breast cancer. Lucy shared her news on…
Comedian Judith Lucy announces she has breast cancer
Australian comedian and actor Judith Lucy has announced she has been diagnosed with breast cancer and will undergo…
How a breast cancer treatment trial changed the lives of Australian women
Donna Rullo wasn’t going down without a fight. It was early 2001, and then-40-year-old Ms Rullo had just…
Exercise linked to better attention and memory after breast cancer
One in three breast cancer survivors will experience cognitive problems, which can include difficulties with attention, memory, processing…
Balkans’ cancer crisis: Late diagnosis and systemic failures
Despite cancer rates similar to Western Europe, patients in the Balkans are far more likely to die from…
Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns
HR+/HER2− breast cancer constitutes approximately 65–75% of all breast cancer cases worldwide. Although CDK4/6 inhibitors have substantially extended progression-free survival (PFS), up…